Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/10/2014 | WO2012075040A3 mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES |
04/10/2014 | WO2012067839A3 Methods of treating neurodegenerative disease |
04/10/2014 | WO2012054468A3 Potyvirus resistance in potato |
04/10/2014 | US20140101792 Plastid tranformation utilizing endogenous regulatory elements |
04/10/2014 | US20140101791 Resistance Genes |
04/10/2014 | US20140101789 Plants Tolerant To Abiotic Stress |
04/10/2014 | US20140101788 Genome shuffling method for autogamous plants utilizing dominant male sterility obtained by gene engineering technique, and recurrent selection breeding system based on the genome shuffling method |
04/10/2014 | US20140100790 Information processing system using nucleotide sequence-related information |
04/10/2014 | US20140100362 Process for Preparing Phosphate Compound Bearing Isotope |
04/10/2014 | US20140100266 Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia |
04/10/2014 | US20140100263 Methods for treatment of alport syndrome |
04/10/2014 | US20140100261 Trpm-2 antisense therapy |
04/10/2014 | US20140100133 Methods for Diagnosing Breast Cancer Using MicroRNAs |
04/10/2014 | US20140100132 Processes for detecting or quantifying more than one nucleic acid in a library |
04/10/2014 | US20140100120 Methods of x-aptamer generation and compositions thereof |
04/10/2014 | US20140100110 Soybean Event DP-305423-1 And Compositions And Methods For The Identification And/Or Detection Thereor |
04/10/2014 | US20140099721 Filamentous fungi having an altered viscosity phenotype |
04/10/2014 | US20140099720 Microorganism expressing xylose isomerase |
04/10/2014 | US20140099719 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
04/10/2014 | US20140099715 High potency sirnas for reducing the expression of target genes |
04/10/2014 | US20140099710 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
04/10/2014 | US20140099702 Divider for use with biolistic bombardment device |
04/10/2014 | US20140099683 Omega-3 desaturase used in the biosynthesis of polyunsaturated fatty acids |
04/10/2014 | US20140099669 Promoter Variants For Expressing Genes In A Fungal Cell |
04/10/2014 | US20140099649 Vesicle capturing devices and methods for using same |
04/10/2014 | US20140099641 Primers for diagnosing ankylosing spondylitis, and method for diagnosing ankylosing spondylitis using the same |
04/10/2014 | US20140099310 Cancer targets and uses thereof |
04/10/2014 | US20140099307 New Dendritic Cell Co-Stimulatory Molecules |
04/10/2014 | US20140097086 Methods for production of proteins |
04/09/2014 | EP2716764A1 Construction and application of mutant type b human adenovirus ad11 having enhanced oncolytic power |
04/09/2014 | EP2716763A2 Genes and uses for plant enhancement |
04/09/2014 | EP2716762A2 Plants having enhanced yield-related traits and a method for making the same |
04/09/2014 | EP2716761A1 A neutralizing RNA aptamer against PDGFR beta and the use thereof in the therapy and diagnosis of hyperproliferative diseases |
04/09/2014 | EP2716760A1 Primer set and method for homologous recombination |
04/09/2014 | EP2716759A1 Gene targeting vector, method for manufacturing same, and method for using same |
04/09/2014 | EP2716758A1 OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PHARMACEUTICAL COMPOSITION FOR DIAGNOSIS, AND OLIGONUCLEOTIDE DERIVATIVE FOR REGULATION OF miRNA FUNCTION |
04/09/2014 | EP2716757A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain |
04/09/2014 | EP2716756A1 Reic-expressing adenovirus vector |
04/09/2014 | EP2716755A1 Attenuated virus of lily mottle virus |
04/09/2014 | EP2716754A1 Improved nitrile hydratase |
04/09/2014 | EP2716753A1 Lipolytic enzyme variants |
04/09/2014 | EP2716752A1 Canine influenza recombinant virus, preparation method therefor and application thereof |
04/09/2014 | EP2716750A1 Uracil-requiring moorella bacteria and transforming-gene-introduced moorella bacteria |
04/09/2014 | EP2716661A1 Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof |
04/09/2014 | EP2716660A1 Cell-penetrating fusion protein for regenerating or proliferating stem cell |
04/09/2014 | EP2716656A1 Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof |
04/09/2014 | EP2716653A1 Truncated human papillomavirus type 33 protein l1 |
04/09/2014 | EP2716652A1 Anti-fatty acid synthase polypeptide and use thereof |
04/09/2014 | EP2716304A1 LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME |
04/09/2014 | EP2716155A2 Transformed caenorhabditis elegans and method for screening for substances regulating glucose metabolism using same |
04/09/2014 | EP2716152A1 Gene associated with non-biological stress resistance, and transformed plant |
04/09/2014 | EP2714936A2 Methods and products for producing engineered mammalian cell lines with amplified transgenes |
04/09/2014 | EP2714933A2 Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies |
04/09/2014 | EP2714932A2 Genes dysregulated in autism as biomarkers and targets for therapeutic pathways |
04/09/2014 | EP2714921A2 Epigenetic co-repressors of the gamma-globin gene and methods of using same |
04/09/2014 | EP2714916A1 Simian adenovirus and hybrid adenoviral vectors |
04/09/2014 | EP2714915A1 Means and methods to induce apomixis in plants |
04/09/2014 | EP2714914A1 Simultaneous site-specific integrations of multiple gene-copies in filamentous fungi |
04/09/2014 | EP2714913A2 Transcription terminator sequences |
04/09/2014 | EP2714912A1 Polycistronic expression system for bacteria |
04/09/2014 | EP2714911A2 Immunogenic composition |
04/09/2014 | EP2714910A1 Immunogenic composition |
04/09/2014 | EP2714909A1 Method of producing factor viii proteins by recombinant methods |
04/09/2014 | EP2714908A1 Immunostimulatory oligodeoxynucleotides |
04/09/2014 | EP2714907A1 Immunostimulatory oligodeoxynucleotides |
04/09/2014 | EP2714906A1 Methods for adjusting expression of mitochondrial genome by microrna |
04/09/2014 | EP2714905A1 Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia |
04/09/2014 | EP2714904A2 Oligonucleotides for modulation of target rna activity |
04/09/2014 | EP2714903A1 Suv39h2 as a target gene for cancer therapy and diagnosis |
04/09/2014 | EP2714902A1 Expression vectors for an improved protein secretion |
04/09/2014 | EP2714901A1 Pest resistant plants |
04/09/2014 | EP2714900A1 Bi-directional cytosine deaminase-encoding selection marker |
04/09/2014 | EP2714897A1 Bilirubin oxidase from magnaporthe oryzae and applications thereof |
04/09/2014 | EP2714896A1 An adult stem cell line introduced with hepatocyte growth factor gene and neurogenic transcription factor gene with basic helix-loop-helix motif and uses thereof |
04/09/2014 | EP2714777A1 Polysaccharide-based hydrogel polymer and uses thereof |
04/09/2014 | EP2714725A1 Chloroplast transit peptides and methods of their use |
04/09/2014 | EP2714723A1 Microbial metabolism of chlorine oxyanions as a control of biogenic hydrogen sulfide production |
04/09/2014 | EP2714066A1 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant |
04/09/2014 | EP2714037A1 Erk inhibitors for use in treating spinal muscular atrophy |
04/09/2014 | EP2713712A2 Transgenic chicken comprising an inactivated immunoglobulin gene |
04/09/2014 | CN203530294U Equipment for preparing biological samples and device for performing biological analysis |
04/09/2014 | CN1543500B Cardiomyocyte precursors from human embryonic stem cells |
04/09/2014 | CN103718045A Method for detecting pancreatic cancer |
04/09/2014 | CN103717754A Method for detecting nucleic acid using intercalator-conjugated metal nanoparticles |
04/09/2014 | CN103717752A Nucleic acid analysis method |
04/09/2014 | CN103717746A Method for producing isopropyl alcohol by continuous culture |
04/09/2014 | CN103717745A Method for producing alkane and recombinant microorganism having alkane-synthesizing ability |
04/09/2014 | CN103717744A Bacterially formed microcin s, a new antimicrobial peptide, effective against pathogenic microorganisms, e.g. enterohemorrhagic escherichia coli (EHEC) |
04/09/2014 | CN103717743A Pavec |
04/09/2014 | CN103717742A Immunogenic composition |
04/09/2014 | CN103717741A Method for enhancing the production yield of human papillomavirus l1 protein |
04/09/2014 | CN103717740A Pharmaceutical composition for treatment and/or prophylaxis of cancer |
04/09/2014 | CN103717739A Pharmaceutical composition for treatment and/or prophylaxis of cancer |
04/09/2014 | CN103717738A Drug composition for cancer treatment and/or prevention |
04/09/2014 | CN103717737A Cancer treatment and/or prevention drug composition |
04/09/2014 | CN103717736A Protein exhibiting fatty acid elongation promoting activity, gene encoding same and use thereof |
04/09/2014 | CN103717735A Technique for cleaving out part of poly(a) chain and/or 3'-terminal sequence of mRNA to inhibit translation reaction |
04/09/2014 | CN103717734A Enzyme function modification method and enzyme variant thereof |
04/09/2014 | CN103717733A A pentose sugar fermenting cell |
04/09/2014 | CN103717732A Methods of increasing yield and stress tolerance in a plant |